A

Assertio Holdings Inc
NASDAQ:ASRT

Watchlist Manager
Assertio Holdings Inc
NASDAQ:ASRT
Watchlist
Price: 1 USD 2.15%
Market Cap: 95.3m USD
Have any thoughts about
Assertio Holdings Inc?
Write Note

Assertio Holdings Inc
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Assertio Holdings Inc
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
A
Assertio Holdings Inc
NASDAQ:ASRT
Other Non-Cash Items
$35.8m
CAGR 3-Years
21%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Non-Cash Items
$3.5B
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Other Non-Cash Items
$14.3B
CAGR 3-Years
6%
CAGR 5-Years
90%
CAGR 10-Years
80%
Pfizer Inc
NYSE:PFE
Other Non-Cash Items
$6.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
35%
Merck & Co Inc
NYSE:MRK
Other Non-Cash Items
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
12%
CAGR 10-Years
27%
Eli Lilly and Co
NYSE:LLY
Other Non-Cash Items
$4.5B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
26%
No Stocks Found

Assertio Holdings Inc
Glance View

Market Cap
95.4m USD
Industry
Pharmaceuticals

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

ASRT Intrinsic Value
1.56 USD
Undervaluation 36%
Intrinsic Value
Price
A

See Also

What is Assertio Holdings Inc's Other Non-Cash Items?
Other Non-Cash Items
35.8m USD

Based on the financial report for Sep 30, 2024, Assertio Holdings Inc's Other Non-Cash Items amounts to 35.8m USD.

What is Assertio Holdings Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
8%

Over the last year, the Other Non-Cash Items growth was -87%. The average annual Other Non-Cash Items growth rates for Assertio Holdings Inc have been 21% over the past three years , 8% over the past five years .

Back to Top